prasugrel

1
Reactions 1414 - 11 Aug 2012 Prasugrel Pruritic maculopapular rash in an elderly patient: case report A 76-year-old woman developed an allergic reaction, manifesting as a pruritic maculopapular rash, while receiving prasugrel. The woman presented with crescendo angina pectoris and narrowing of the left anterior descending artery, and underwent a percutaneous coronary intervention. Seven years previously, she had developed a hypersensitivity reaction of clopidogrel, and so she was administered prasugrel at a loading dose of 60mg, followed by a maintenance dosage of 10mg daily [route not stated]. Two days later, she developed a pruritic maculopapular rash on her limbs and trunk. Prasugrel was switched to clopidogrel, and the woman received prednisone, cetirizine and chlorphenamine to facilitate physiological tolerance. Four days later, her rash resolved. At 1 month follow-up, anti-allergic therapy was withdrawn, and the rash did not recur. Author comment: "[C]lopidogrel therapy is critical in patients following percutaneous coronary interventions and often cannot be stopped even in cases of adverse drug response. Alternative treatment with prasugrel can cross-react and leads to a similar adverse reaction." Raccah BH, et al. Allergic reaction to prasugrel and cross-reactivity with clopidogrel. International Journal of Cardiology 157: e48-e49, No. 3, 14 Jun 2012. Available from: URL: http://dx.doi.org/10.1016/j.ijcard.2011.09.051 - Israel 803075184 1 Reactions 11 Aug 2012 No. 1414 0114-9954/10/1414-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: builien

Post on 19-Mar-2017

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Prasugrel

Reactions 1414 - 11 Aug 2012

Prasugrel

Pruritic maculopapular rash in an elderly patient:case report

A 76-year-old woman developed an allergic reaction,manifesting as a pruritic maculopapular rash, whilereceiving prasugrel.

The woman presented with crescendo angina pectorisand narrowing of the left anterior descending artery, andunderwent a percutaneous coronary intervention. Sevenyears previously, she had developed a hypersensitivityreaction of clopidogrel, and so she was administeredprasugrel at a loading dose of 60mg, followed by amaintenance dosage of 10mg daily [route not stated]. Twodays later, she developed a pruritic maculopapular rash onher limbs and trunk.

Prasugrel was switched to clopidogrel, and the womanreceived prednisone, cetirizine and chlorphenamine tofacilitate physiological tolerance. Four days later, her rashresolved. At 1 month follow-up, anti-allergic therapy waswithdrawn, and the rash did not recur.

Author comment: "[C]lopidogrel therapy is critical inpatients following percutaneous coronary interventions andoften cannot be stopped even in cases of adverse drugresponse. Alternative treatment with prasugrel can cross-reactand leads to a similar adverse reaction."Raccah BH, et al. Allergic reaction to prasugrel and cross-reactivity withclopidogrel. International Journal of Cardiology 157: e48-e49, No. 3, 14 Jun 2012.Available from: URL: http://dx.doi.org/10.1016/j.ijcard.2011.09.051 -Israel 803075184

1

Reactions 11 Aug 2012 No. 14140114-9954/10/1414-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved